|
|
Article: Callisto Announces Availability of Presentation Outlining Drug Development Pipeline and Market Opportunities; Development Programs Include New Drugs to Treat Leukemia and Multiple Myeloma Cancers, and to Fight Biowarfare Threats.
- Article from:
- Business Wire
- Article date:
- October 13, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- Callisto Pharmaceuticals, Inc. (AMEX:KAL)(FWB:CA4), a developer of new drug treatments in the fight against hematological cancers and related diseases, has announced the online availability of an electronic presentation that provides an informative overview of the Company's development pipeline of needed drugs to treat diseases including blood cancers and serious gastrointestinal inflammation, as well as its program to develop drugs to protect against biowarfare agents for use in homeland security applications.
The presentation, available to all interested investors, provides an overview of the multi-million-dollar markets for the Company's drug ...
Related newspaper, magazine, and journal articles:
|
|
Article: Callisto Pharmaceuticals Announces Additional ...
Internet Wire;
January 31, 2005 ;
700+ words
... ... COMTEX) Callisto Pharmaceuticals, Inc ... treatment of multiple myeloma (MM ... relapsed multiple myeloma, and 3 ... effect in multiple myeloma patients. About Callisto Pharmaceuticals, Inc. Callisto ...
|
|